Advertisement

Regulatory mediators in Arthus reactions: demonstration of chemotactic factor inactivator and cell directed inhibitor activity

  • G. Till
  • M. Debatin
  • D. Gemsa
Part of the Inflammation: Mechanisms and Treatment book series (FTIN, volume 4)

Abstract

The study of Arthus reactions has led investigators to a better understanding of the underlying pathogenic mechanism of inflammatory tissue injury evoked by local deposition of complement-activating antigen-antibody complexes. It is well accepted that neutrophils and complement are essential for the mediation of Arthus reactions. In various animal species an Arthus reaction could be inhibited by depletion of the circulating neutrophils with nitrogen mustard1 or specific antiserum2. Depletion of complement with cobra venom factor pretreatment also inhibited Arthus reactions3. The accumulation of neutrophils, which is essential for tissue injury, is probably mediated by complement-derived chemotactic factors. In reversed passive Arthus reactions C5 chemotactic factors could be demonstrated in rat dermis4. Upon intradermal injection into guinea pigs of complement-derived chemotactic factors, accumulation of intravenously administered 51Cr-labelled homlo-gous neutrophils could be observed5.

Keywords

Chemotactic Factor Chemotactic Activity Regulatory Mediator Arthus Reaction Passive Arthus Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stetson, C.A. (1951). Similarities in the mechanisms determining the Arthus and the Schwartzman phenomena. J. Exp. Med., 94, 349Google Scholar
  2. 2.
    Cochrane, C. G., Unanue, E. and Dixon, F.J. (1965). A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J. Exp. Med., 122, 99PubMedCrossRefGoogle Scholar
  3. 3.
    Cochrane, C. G., Müller-Eberhard, H.J. and Aikin, B. S. (1970). Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J. Immunol., 105, 55PubMedGoogle Scholar
  4. 4.
    Ward, P. A. and Hill, J. A. (1972). Biological role of complement products. Complement-derived leukotactic activity extractable from lesions of immunologic vasculitis. J. Immunol., 108,1137PubMedGoogle Scholar
  5. 5.
    Jones, D. G., Richardson, D. L. and Kay, A. B. (1977). Neutrophil accumulatioon in vivo following the administration of chemotactic factors. Br. J. Haematol. 35,19PubMedCrossRefGoogle Scholar
  6. 6.
    Goetzl, E.J. and Austen, K. F. (1972). A neutrophil immobilizing factor derived from human leukocytes. I. Generation and partial characterization. I. Exp. Med, 136, 1564CrossRefGoogle Scholar
  7. 7.
    Maderazo, E. G., Anton, T. F. and Ward, P. A. (1978). Serum associated inhibitor of leuko-taxis in humans with cancer. Clin. Immunol. Immunopathol., 9,166PubMedCrossRefGoogle Scholar
  8. 8.
    Berenberg, J. A. and Ward, P. A. (1973). Chemotactic factor inactivator in normal human serum. J. Clin. Invest., 52,1200PubMedCrossRefGoogle Scholar
  9. 9.
    Till, G. and Ward, P. A. (1975). Two distinct chemotactic factor inactivators in human serum. J. Immunol., 114, 843PubMedGoogle Scholar
  10. 10.
    Johnson, K. J., Anderson, T. P. and Ward, P. A. (1977). Suppression of immune complex-induced inflammation by the chemotactic factor inactivator. J. Clin. Invest., 59, 951PubMedCrossRefGoogle Scholar
  11. 11.
    Boyden, S.V. (1962). The chemotactic effect of mixtures of antibody and antigen on poly-morphonuclear leukocytes.J. Exp. Med. 115,453PubMedCrossRefGoogle Scholar
  12. 12.
    Zigmond, S.H. and Hirsch, J. G. (1973). Leukocyte locomotion and Chemotaxis. New methods for evaluation and demonstration of a cell-derived chemotactic factor. J. Exp. Med., 137, 387PubMedCrossRefGoogle Scholar
  13. 13.
    Mayer, M. M. (1961). Complement and complement fixation. In Kabat and Mayer (eds.) Experimental Immunochemistry, pp. 133. (Thoma; Springfield)Google Scholar
  14. 14.
    Brozna, J.P., Senior, R.M. Kreutzer, D.L. and Ward, P. A. (1977). Chemotactic factor inactivators of human granulocytes. J. Clin. Invest., 60,1280PubMedCrossRefGoogle Scholar
  15. 15.
    Debatin, K. M., Gemsa, D. and Till, G. (1980). Regulatory mediators in Arthus reactions. II. Lysosomal enzymes in biopsy and serum. This volume, Chap. 91Google Scholar
  16. 16.
    Maderazo, E. G., Ward, P. A., Woronick, C. L. and Quintiliani, R. (1977). Partial characterization of a cell-directed inhibitor of leukotaxis in human serum. J. Lab. Clin. Med., 89, 180Google Scholar

Copyright information

© MTP Press Limited 1980

Authors and Affiliations

  • G. Till
    • 1
  • M. Debatin
    • 1
  • D. Gemsa
    • 1
  1. 1.West Germany

Personalised recommendations